Healius Limited (ASX: HLS)
Australia
· Delayed Price · Currency is AUD
1.315
-0.025 (-1.87%)
Nov 21, 2024, 4:10 PM AEST
Healius Revenue
In the fiscal year ending June 30, 2024, Healius had annual revenue of 1.75B AUD with 2.30% growth. Healius had revenue of 897.20M in the half year ending June 30, 2024.
Revenue
1.75B
Revenue Growth
-5.05%
P/S Ratio
0.50
Revenue / Employee
249.67K
Employees
9,658
Market Cap
954.86M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 1.75B | 39.30M | 2.30% |
Jun 30, 2023 | 1.71B | -582.00M | -25.43% |
Jun 30, 2022 | 2.29B | 374.70M | 19.57% |
Jun 30, 2021 | 1.91B | 344.40M | 21.94% |
Jun 30, 2020 | 1.57B | 3.40M | 0.22% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
ResMed Inc. | 6.93B |
Pro Medicus Limited | 161.50M |
Fisher & Paykel Healthcare Corporation Limited | 1.60B |
Cochlear Limited | 2.24B |
Sonic Healthcare Limited | 8.97B |
Ramsay Health Care Limited | 16.66B |
Telix Pharmaceuticals Limited | 645.68M |